poisar

Stocks · News reference

UBS Maintains Neutral on Envista Holdings, Raises Price Target to $29

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    Envista Q3 Earnings Call Highlights '26 Guidance Raise & China Risks

    Envista Holdings (NVST) raised its 2026 adjusted EPS guidance to $1.54-$1.58 and EBITDA growth outlook to 12.5%-14% following strong Q3 results with 25% earnings growth. However, China's upcoming volume-based procurement reforms threaten to cut orthodontics prices by 50% and implant prices by 10%-15% in 2027, pressuring future margins despite management's confidence in margin expansion outside China.